Open Access Research article

FE65 as a link between VLDLR and APP to regulate their trafficking and processing

Sonya B Dumanis1, Kelly A Chamberlain1,2, Yoo Jin Sohn1,2, Young Jin Lee1,2, Suzanne Y Guénette9, Toshiharu Suzuki4, Paul M Mathews5, Daniel TS Pak3, G William Rebeck1, Yoo-hun Suh6,7, Hee-Sae Park8 and Hyang-Sook Hoe1,2*

1 Department of Neuroscience, Georgetown University Medical Center, 3970 Reservoir Road NW, Washington, DC 20057-1464, USA

2 Department of Neurology, Georgetown University Medical Center, 3970 Reservoir Road NW, Washington, DC 20057-1464, USA

3 Department of Pharmacology, Georgetown University Medical Center, 3970 Reservoir Road NW, Washington, DC 20057-1464, USA

4 Laboratory of Neuroscience, Graduate School of Pharmaceutical Science, Hokkaido University, Sapporo, Japan

5 Nathan Kline Institute for Psychiatric Research, Orangeburg, New York, USA

6 Department of Pharmacology, College of Medicine, Neuroscience Research Institute, MRC, Seoul National University, Seoul, South Korea

7 Hormone Research Center, School of Biological Sciences and Technology, Chonnam National University, Gwangju 500-757, Republic of Korea

8 Genetics and Aging Research Unit, Mass General Institute for Neurodegenerative Disease, Harvard Medical School, Charlestown, MA

9

For all author emails, please log on.

Molecular Neurodegeneration 2012, 7:9 doi:10.1186/1750-1326-7-9

Published: 19 March 2012

Additional files

Additional file 1:

Figure S1. The FE65 PTB2 domain does not interact with VLDLR. A. Constructs of FE65 with C-terminal GFP tags containing only PTB2 (construct #1) and full length FE65 (construct # 2). B. COS7 cells were transfected with VLDLR-myc and GFP, FE65 PTB2-GFP or full length FE65-GFP. Cell lysates (100 ug) were immunoprecipitated with 5F3 antibody (for VLDLR) and probed with an anti-GFP antibody (for FE65). Full length FE65 immunoprecipitates with VLDLR, but not the FE65 containing only the PTB2 domain (first panel). Conversely, cell lysates (100 ug) were immunoprecipitated with GFP (for FE65) and probed with an anti-myc (for VLDLR) (second panel). Western blot analysis showing comparable expression levels of the two FE65 constructs and VLDLR (third and fourth panel).

Format: PDF Size: 73KB Download file

This file can be viewed with: Adobe Acrobat Reader

Open Data

Additional file 2:

Figure S2. FE65 Knockout mice have increased APP processing. 13 month old FE65 knockout mice or wild-type littermates were immunoblotted with FE65, C1/6.1 (for APP), and β-actin. FE65 knockout mice had increased levels of full length APP and APP CTF compared to wild type littermates.

Format: PDF Size: 40KB Download file

This file can be viewed with: Adobe Acrobat Reader

Open Data